SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Barron Von Hymen who wrote (1530)4/23/1998 5:11:00 PM
From: Anthony Wong  Respond to of 9523
 
Perhaps some people found the VVUS stock price "cheap". If I have the money, I'll rather buy 100 shares of PFE than 1000 shares of VVUS. PFE has so many otehr drugs in the pipeline. PFE hadn't done too poorly today, up 3/4 point. Seems not many are selling. Looking forward to next Monday's script number....



To: Barron Von Hymen who wrote (1530)4/23/1998 5:18:00 PM
From: Cosmo Daisey  Read Replies (1) | Respond to of 9523
 
Barron,
Muse has been on the market for some time now and has advertised the treatment widely to no avail. The price has plummeted from the 40's.
Side effects are also noticed in the partner, not just the patient.
Roth is a MM and also takes care of news releases and promotion for many clients.
cdaiseyPhD@muse-ouch.com



To: Barron Von Hymen who wrote (1530)4/23/1998 7:17:00 PM
From: zx  Read Replies (2) | Respond to of 9523
 
hi Barron, i am just sad i did not buy VVUS yesterday.
people at SI were talking about buying it.
the possibility of using VVUS and PFE in combination ED therapy. ag


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News